Become a Prostate Cancer Research Consumer Reviewer

Interested in contributing to prostate cancer research? Read on to learn more. 

About the Prostate Cancer Research Program's Consumer Reviewer Program

The Prostate Cancer Research Program (PCRP) began in 1997 as a part of the Congressionally Directed Medical Research Programs, or CDMRP. Created by Congress in 1992 and administered by the Department of Defense, CDMRP programs advance biomedical research, with a particular focus on applied research that supports the greatest needs of the disease community and U.S. service members.

Prostate cancer is a real threat to men who serve in the U.S. military; 1 in 5 Veterans and active-duty military will be diagnosed with the disease in their lifetime.

The PCRP is dedicated to supporting high-risk, high-reward research with near-term clinical application to eradicate prostate cancer deaths and promote groundbreaking development of new tests and treatments. The PCRP has contributed to developing 7 new treatments in the
last decade, including multiple therapies for metastatic prostate cancer that no longer respond to other treatments.

A key component of the PCRP is the Consumer Reviewer Panel, composed of patients, providers, and clinicians who act as lay experts on prostate cancer, bringing their lived experiences and perspectives to the evaluation of research grant proposals. This helps ensure that the research conducted will make a meaningful difference in the lives of prostate cancer patients. 

To learn more about being a Reviewer and submit your name for consideration, please see the FAQ below. If you have additional questions, please email advocacy@zerocancer.org. You may also visit the CDMRP website for additional information.

Frequently Asked Questions

Share